CIAM
RVMD icon

Caitong International Asset Management’s Revolution Medicines RVMD Stock Holding History

Caitong International Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$369K Buy
+3,795
New +$383K 0.07% 242
2025
Q3 		– Sell
-3,386
Closed -$125K – 2433
2025
Q2 		$125K Buy
3,386
+3,385
+338,500% +$130K 0.09% 126
2025
Q1 		$35 Buy
+1
New +$41 ﹤0.01% 2058

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Caitong International Asset Management's RVMD Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Revolution Medicines (RVMD) in Q1 2026: 3,795 shares worth $369K. The stake represents 0.07% of the portfolio and ranks #242 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in RVMD as recently as Q2 2025.

Caitong International Asset Management first reported a position in RVMD in Q1 2025 and has held it in 3 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Caitong International Asset Management held 3,795 shares of Revolution Medicines worth $369K as of Q1 2026.
  • Revolution Medicines was a new Caitong International Asset Management position in Q1 2026.
  • Revolution Medicines made up 0.07% of Caitong International Asset Management's portfolio in Q1 2026, its #242 holding.
  • Caitong International Asset Management first reported a position in Revolution Medicines in Q1 2025 and has held it in 3 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.